Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Bio-Techne logoBio-Techne TECH

The company said the expiration dates for 779,084 shares under outstanding vested options held by former employees were in dispute. Those options were granted in 2017 to former President and Chief Executive Officer Charles R. Kummeth. Under the award agreements, the expiration date was August 9, 2024.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said the expiration dates for 779,084 shares under outstanding vested options held by former employees were in dispute. Those options were granted in 2017 to former President and Chief Executive Officer Charles R. Kummeth. Under the award agreements, the expiration date was August 9, 2024.

  2. The company said an administrative error caused its stock plan administration platform to show the option expiration date incorrectly as October 26, 2024. Kummeth tried to exercise the options in September 2024 and was notified that they had expired. He then filed for arbitration under the agreement.

  3. The company said an arbitrator issued an order in favor of Kummeth on February 26, 2025. The arbitrator concluded that, without the administrative error, he would have exercised the options before the August 9, 2024 expiration date. The arbitrator also required payment of about $35,978,000 related to the options.

  4. The company said the arbitrator also required it to pay interest of about $980,000 and legal fees and costs of about $234,000 required under the award agreements, in addition to about $35,978,000 related to the options.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

2017 Option Expiration Date Dispute

The company said the expiration dates for 779,084 shares under outstanding vested options held by former employees were in dispute. Those options were granted in 2017 to former President and Chief Executive Officer Charles R. Kummeth. Under the award agreements, the expiration date was August 9, 2024.

Source · Based on the filing body and exhibits

Expiration Date Error and Arbitration Filing

The company said an administrative error caused its stock plan administration platform to show the option expiration date incorrectly as October 26, 2024. Kummeth tried to exercise the options in September 2024 and was notified that they had expired. He then filed for arbitration under the agreement.

Source · Based on the filing body and exhibits

Arbitration Order on February 26, 2025

The company said an arbitrator issued an order in favor of Kummeth on February 26, 2025. The arbitrator concluded that, without the administrative error, he would have exercised the options before the August 9, 2024 expiration date. The arbitrator also required payment of about $35,978,000 related to the options.

Source · Based on the filing body and exhibits

Interest and Legal Fees Payment Demanded

The company said the arbitrator also required it to pay interest of about $980,000 and legal fees and costs of about $234,000 required under the award agreements, in addition to about $35,978,000 related to the options.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.